Do you want to receive the latest myeloma news and research for free, directly in your email inbox? You can with the Myeloma Minute!

Subscribe below to receive weekly email newsletters with up-to-the 'minute' information about multiple myeloma. The Myeloma Minute includes:

  • blogs and videos from Dr. Brian G.M. Durie,
  • inspirational videos,
  • information about drug recalls,
  • research announcements,
  • patient support events,
  • regional educational outreach,
  • advocacy action, and more.
Stay in Touch for the Latest Information
For late breaking news and events, subscribe to the Myeloma Minute!
The September 7, 2017 issue covers the recent flurry of myeloma clinical trial closures by the FDA, the Lancet Oncology publication of data on overall survival benefits from Kyprolis® (carfilzomib) in the phase III ENDEAVOR trial, and more.
The August 31, 2017 issue covers daratumumab clinical trial news, the first-ever CAR T-cell therapy approval in the U.S., and more.
The August 24, 2017 covers how newly diagnosed myeloma patients who undergo an autologous stem cell transplant and follow it with Revlimid® (lenalidomide) maintenance, have longer progression-free survival and a significant overall survival benefit, and more.
The August 17, 2017 issue covers webinars, seminars, patient stories, and volunteer fundraisers.
The August 10, 2017 issue covers the FDA's Expanded Access Navigator, clinical trials for patients with solitary plasmacytoma of bone (SPB), and more.
The August 3, 2017 issue discusses CRISPR Cas-9 gene editing and provides a free set of educational slides.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.